Skip to content

Clinical observation on the application of Jianpi Yichang powder based on the theory of "regulating the middle and restoring balance" to prevent postoperative recurrence of spleen deficiency type intestinal polyps

Clinical observation on the application of Jianpi Yichang powder based on the theory of "regulating the middle and restoring balance" to prevent postoperative recurrence of spleen deficiency type intestinal polyps

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000347
Enrollment
Unknown
Registered
2024-09-01
Start date
2024-01-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic polyps

Interventions

observation group:No medication intervention, routine follow-up evaluation
Test group:The experimental group was given a self formulated traditional Chinese medicine "Jianpi Yichang San" orally, twice a day, with warm water for 7 days as one course of treatment. There are th

Sponsors

Third Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Western endoscopy and traditional Chinese medicine syndrome diagnosis; At the time of enrollment the pathological diagnosis of intestinal polyps was adenoma with an age range of 18-80 years and no gender limitation; 3. Clear consciousness can cooperate with treatment; 4. No serious internal medicine diseases such as cardiovascular and pulmonary diseases; 5. Agree to participate in clinical research and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Familial polyposis and inflammatory bowel disease; P-J syndrome (2) Colorectal cancer; (3) Patients with severe primary diseases such as cardiovascular, cerebrovascular, pulmonary, hepatic, renal, and hematopoietic systems; (4) Individuals who are allergic to this medication; (5) Individuals with abnormal mental states; (6) Participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Adenoma recurrence rate;

Secondary

MeasureTime frame
Traditional Chinese Medicine Syndrome Rating Scale;

Countries

China

Contacts

Public ContactWang Zhe

Third Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine

cjwdwz@126.com+86 158 0451 4492

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026